Form 8-K - Current report:
SEC Accession No. 0001445305-13-000138
Filing Date
2013-02-01
Accepted
2013-02-01 16:30:38
Documents
2
Period of Report
2013-02-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K sohoindonesiaagreement8k.htm 8-K 46619
2 cumberlandpicture.jpg GRAPHIC 35104
  Complete submission text file 0001445305-13-000138.txt   96126
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 13567083
SIC: 2834 Pharmaceutical Preparations